brequinar has been researched along with Ebola Hemorrhagic Fever in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anantpadma, M; Basler, CF; Bukreyev, A; Davey, RA; De, S; Edwards, MR; Khadka, S; Luthra, P; Naidoo, J; Pietzsch, CA; Ready, JM; Williams, CG | 1 |
1 other study(ies) available for brequinar and Ebola Hemorrhagic Fever
Article | Year |
---|---|
Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
Topics: A549 Cells; Antiviral Agents; Biphenyl Compounds; Carbazoles; Dihydroorotate Dehydrogenase; DNA Damage; Ebolavirus; HEK293 Cells; Hemorrhagic Fever, Ebola; Host-Pathogen Interactions; Humans; Immune Evasion; Immunity, Innate; Interferon Regulatory Factor-1; Interferon-alpha; Interferon-beta; Nucleosides; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidines; RNA Viruses; Signal Transduction; Vesiculovirus; Virus Replication; Zika Virus | 2018 |